ERBB2 and triple-negative breast carcinoma: Triple negative breast cancers (TNBCs) are defined by a lack of estrogen receptor expression and progesterone receptor expression, as well as an absence of human epidermal growth factor receptor 2 (ERBB2/HER2) amplification.